BO-264 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a potent inhibitor targeting specific enzymes or receptors involved in disease pathways, particularly in oncology. Researchers are exploring its potential in cancer therapy due to its ability to disrupt cellular processes that promote tumor growth. Additionally, BO-264 is being studied for its application in treating inflammatory and autoimmune disorders, where it may help modulate immune responses. Its precise mechanism of action makes it a promising candidate for developing targeted therapies with reduced side effects. Ongoing preclinical studies aim to further validate its efficacy and safety for potential clinical use.